Posted inBiotechnology
BioNTech’s HER2 ADC beats Roche’s Kadcyla in phase 3 breast cancer trial
BioNTech’s HER2 antibody-drug conjugate has beaten Roche’s Kadcyla in a phase 3 breast cancer trial, positioning the company’s partner Duality…
Posted inBiotechnology
Chutes & Ladders—Merck KGaA lands new R&D chief
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please…
Posted inMedical Technology
Galvanize Therapeutics nets $100M, and a new CEO, to bring pulsed field ablation to lung cancer
Galvanize Therapeutics has raised $100 million in venture capital backing—and is making a change in leadership—to help energize its development…
Posted inBiotechnology
FDA moves to publish drug rejection letters in real time, releases new batch including Replimune’s high-profile snub
The FDA today announced a plan to publicly release complete response letters at the same time they are issued to…
Posted inMedical Technology
Quest Diagnostics launches new pharmacogenomics testing program
Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to…
Posted inBiotechnology
VC Atlas lands $400M to support existing biotech portfolio
Nine months after closing a $450 million fundraise, Atlas Venture is back with another biotech financing vehicle, raising $400 million…
Posted inBiotechnology
AC Immune cuts workforce by 30%, trims pipeline to preserve cash
AC Immune is reducing its workforce by around 30% and narrowing its pipeline to extend its cash runway by about six…
Posted inBiotechnology
Enveda harvests another $150M to advance nature-inspired drugs
Enveda has closed its second $150 million financing round of the year. The series D round, which moves Enveda’s total funding…
Posted inMedical Technology
Illumina begins rolling out protein prep platform ahead of SomaLogic buy
Illumina has begun rolling out its protein research platform, powered in part by tech from SomaLogic, which the DNA sequencing…
Posted inResearch
Australian biotech Filamon partners with Pi Health for anti-inflammatory cancer trial
Global CRO Pi Health has pulled a new partnership out of the oven. Building on a growing presence Down Under,…